X0407 4 2023-03-31 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001031847 MILLER RICHARD A MD C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 true true President and CEO false Stock Option (Right to Buy) 0.91 2023-03-31 4 A 0 800000 0 A 2033-03-31 Common Stock 800000 800000 D The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from March 31, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller 2023-04-03